Gotrade News - Q1 2026 earnings season is heating up with major corporate reports delivering sharply divergent results across the healthcare, financial services, and aviation sectors. Intuitive Surgical posted strong revenue growth but saw shares slide after hours, while Capital One missed estimates and United Airlines dramatically slashed its full-year earnings guidance.
The mixed signals underscore a market grappling with increasingly divergent sector-specific headwinds even as broad corporate revenue growth continues into the second quarter. Investors are parsing each report carefully for clues about consumer credit deterioration, healthcare capital spending patterns, and the sustainability of post-pandemic travel demand.
Key Takeaways
- Intuitive Surgical delivered 23% year-over-year revenue growth and raised its procedure guidance, yet shares fell 3% as investors questioned mounting headwinds across Asian hospital markets.
- Capital One missed both EPS and revenue estimates as credit loss provisions swelled to $4.1 billion, signaling consumer credit stress is intensifying faster than Wall Street had anticipated.
- United Airlines beat on Q1 earnings but slashed full-year EPS guidance to $7-$11 from $12-$14, undermining the travel recovery narrative that had supported airline stock valuations.
Intuitive Surgical Beats but Stumbles on Asia Headwinds
Intuitive Surgical reported Q1 revenue of $2.77 billion, handily beating Wall Street consensus estimates and surging 23% compared to the same quarter a year ago. Adjusted earnings per share came in at $2.50, also clearing the bar that analysts had set for the dominant surgical robotics market leader ahead of the quarterly print.
CEO David Rosa called Q1 "a solid start to the year for Intuitive," highlighting 17% total procedure growth driven by broad-based adoption across both da Vinci and Ion platforms. The company placed 431 new da Vinci systems during the quarter, pushing its cumulative global installed base to an impressive 11,395 units across hospitals worldwide.
Management raised full-year procedure growth guidance to a range of 13.5%-15.5%, up meaningfully from earlier projections that the market had previously viewed as overly conservative. Gross margin expectations also ticked higher to a favorable range of 67.5%-68.5%, reflecting the pricing power and strong operating leverage that come with a rapidly expanding global installed base.
The da Vinci 5 platform and newer Ion lung biopsy system are driving upgrades at hospitals worldwide, broadening the product portfolio beyond traditional surgical robotics. Despite this momentum, ISRG shares fell 3.07% to $451.29 in post-market trading as investors zeroed in on a cluster of geographic headwinds.
Management specifically flagged limited China hospital tender activity, competitive pricing pressure across broader Asian markets, and persistent capital constraints at Japanese hospitals. These headwinds matter because Asia represents Intuitive's single largest growth opportunity outside the United States and Western Europe, and sustained purchasing delays could meaningfully narrow the long-term growth runway.
Capital One and United Airlines Signal Consumer Pressure
Capital One Financial reported adjusted earnings per share of $4.42, missing the $4.55 consensus estimate by a margin that caught many analysts off guard. Total revenue of $15.23 billion also fell short of the $15.36 billion figure that Wall Street had been modeling heading into the quarterly earnings report.
The more alarming detail buried in the quarterly report was Capital One's $4.1 billion credit loss provision, accompanied by net charge-offs totaling $3.8 billion for the period. These figures strongly suggest that consumer credit deterioration is accelerating meaningfully in the subprime card segments where Capital One carries its most concentrated lending exposure.
Pre-provision earnings did rise a solid 8% to $6.8 billion, indicating that the core lending franchise remains operationally healthy and continues to generate strong spread income for shareholders. However, rising loss rates are steadily consuming that top-line revenue growth before it reaches the bottom line, creating a persistent margin squeeze that could worsen in coming quarters.
COF shares declined a relatively muted 1.56% to $202.50, suggesting that investors had already priced in a degree of credit normalization pressure on near-term results. The restrained market reaction indicates Wall Street views this as cyclical credit deterioration rather than a structural threat to Capital One's core consumer lending business model.
United Airlines delivered an impressive Q1 revenue beat at $14.61 billion, climbing a healthy 10.6% year-over-year, with adjusted EPS of $1.19 topping Wall Street expectations. Premium cabin revenue surged a robust 14% while the high-margin loyalty program division grew 13%, both meaningfully outperforming the consensus estimates that analysts had published ahead of the report.
The headline that crushed investor sentiment, however, was the full-year earnings guidance cut from a prior range of $12-$14 down to just $7-$11 per share. UAL shares slipped 1.80% to $97.13 as the market digested the severity of a downward revision representing a roughly 35% reduction at the midpoint of the original range.
The dramatic guidance reduction signals that United's management team sees significant demand uncertainty in the second half of 2026 despite executing well through the first quarter. Rising jet fuel costs, ongoing geopolitical disruptions affecting international route profitability, and the increasing potential for a broader consumer spending pullback likely all informed this conservative forward revision.
Taken together, these three Q1 reports paint a nuanced picture of an economy where corporate innovation spending remains robust but consumer-facing sectors are absorbing growing headwinds. For global retail investors watching from the sidelines, the widening divergence between healthcare strength and financial-consumer weakness may well define the investment playbook for the remainder of this earnings season.
Sources
Seeking Alpha, Intuitive Surgical Forecasts Strong Procedure Growth for 2026, 2026.
Benzinga, ISRG, Capital One, United Airlines Post Mixed Q1 Results, 2026.
